News & Analysis on Clinical Trial Services & Contract Research And Development
Discovery Laboratories is claiming progress in its struggle to correct manufacturing problems related to Surfaxin, its experimental respiratory treatment for infants, yet the goal of overcoming the process validation issues that prevent it from...
Cardinal Health is the latest firm to benefit from Roche's global recruitment drive for manufacturers to help boost its supplies of the bird flu drug coveted by governments across the world - Tamiflu.
Maryland is no longer in the running for a $500m (€392m) vaccine manufacturing plant Novartis is seeking to build in the US, as speculation about which state will host America's first cell culture-derived influenza vaccine plant is reaching fever pitch.
Takeda Pharmaceutical has jumped at the chance to use a new technology that its developer, Spherics, claims can improve the efficacy of a drug while reducing side effects, providing more consistent drug levels and enhancing compliance.
Thermo Electron introduces its solution for researchers involved in large volume pipetting, making available a pipetting aid that incorporates a motor to allow faster pipetting of volumes saving time and cost without compromising accuracy and safety.
Chemicon are to supply drug targets for MorphoSys in a licensing agreement that will see MorphoSys develop antibodies from its proprietary HuCAL Gold antibody library.
Isopak is flaunting a new automatic check weigher for capsules and tablets, promising more accuracy than ever before.
Locus Pharmaceuticals has announced it has entered a drug discovery agreement with Ono Pharmaceuticals in a deal that will focus on protein kinases as a molecular target.